Loading...
Type 2 diabetes, thiazolidinediones, and cardiovascular risk
Type 2 diabetes is a common disorder with an increased risk of macrovascular complications. Achieving adequate glycaemic control is an important aim of therapy. Thiazolidinediones, or glitazones, have been used for the treatment of diabetes for a decade. Rosiglitazone and pioglitazone are currently...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Royal College of General Practitioners
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2702020/ https://ncbi.nlm.nih.gov/pubmed/19567003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3399/bjgp09X453440 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|